Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 16Mouth Neoplasms 7Squamous Cell Carcinoma of Head and Neck 4Oropharyngeal Neoplasms 4Laryngeal Neoplasms 4Hypopharyngeal Neoplasms 4Tongue Neoplasms 2Salivary Gland Neoplasms 2Paranasal Sinus Neoplasms 2Nasopharyngeal Neoplasms 2Nasopharyngeal Carcinoma 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Stomatitis 1Recurrence 1Precancerous Conditions 1Pharyngeal Neoplasms 1Papilloma 1Neoplasms 1Mucositis 1Leukoplakia, Oral 1Laryngeal papillomatosis 1Adenocarcinoma, Follicular 1

Interventions

Cisplatin 7Cetuximab 5Drug Therapy 4Radiotherapy 3Resistance Training 2Radiotherapy, Intensity-Modulated 2Nutritional Status 2Hydroxyurea 2Fluorouracil 2Erlotinib Hydrochloride 2Bevacizumab 2zimberelimab 1temsirolimus 1pembrolizumab 1Valproic Acid 1Sirolimus 1Radiation 1Quality of Life 1Psychology, Positive 1Patient Reported Outcome Measures 1Oncolytic Virotherapy 1Molecular Diagnostic Techniques 1Methods 1Metabolic Flux Analysis 1Immunotherapy 1Immunoglobulin G 1Etoposide 1Docetaxel 1Disulfides 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pharyngeal Neoplasms × Celecoxib × Head & Neck × Clear all
NCT00970502 2017-04-10

Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer

Icahn School of Medicine at Mount Sinai

Phase 1/2 Completed
15 enrolled 16 charts
Head & Neck

Head and Neck Neoplasms, Laryngeal Neoplasms, Paranasal Sinus Neoplasms, Pharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡